Invitae Corporation, a leading medical genetics company, has announced that it has entered into a definitive agreement to acquire Jungla Inc., a privately held company funded by Andreessen Horowitz (a16z) that has developed a cloud-based platform that combines clinical knowledge with advances in functional genomics, biophysics, cellular engineering, machine learning, and distributed systems to help clinicians and patients understand the results of genetic and genomic tests, as detailed in the company press release. The combination is expected to further enhance Invitae’s genetic variant interpretation and ability to deliver high-quality, more affordable genetic testing for use in mainstream medical care.
Latham & Watkins LLP represents Jungla Inc. in the transaction with a Silicon Valley based corporate deal team led by partners Benjamin Potter and Mark Bekheit with associates Michelle Lu and David Chen. Advice was also provided on benefits and compensation matters by Silicon Valley associates Ashley Wagner and Mi Zhou; on data privacy matters by San Francisco associate Heather Deixler; on tax matters by San Francisco partner Grace Lee with associate Jessica Chen; and on technology transaction matters by Silicon Valley partner Anthony Klein with associate Gil Halpern.
Date: July 22, 2019
Source: BioSpace
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
